Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-736-0234
Summary
- Joseph C. Wu, MD, PhD, is Director of the Stanford Cardiovascular Institute and the Simon H. Stertzer, MD, Professor of Medicine & Radiology. He is President of the American Heart Association (June 2023 - July 2024).
Dr. Wu received his medical degree from Yale. He completed his medicine internship, residency and cardiology fellowship training at UCLA followed by a PhD (Molecular & Medical Pharmacology) in the UCLA STAR program. His clinical activities involve adult congenital heart disease and cardiovascular imaging.
Dr. Wu has received numerous awards, including National Institutes of Health (NIH) Director’s New Innovator Award, NIH Roadmap Transformative Award, American Heart Association (AHA) Innovative Research Award, Presidential Early Career Award for Scientists and Engineers (PECASE) given out by President Obama, AHA Established Investigator Award, Burroughs Wellcome Foundation Innovation in Regulatory Science Award, AHA Merit Award, and AHA Distinguished Scientist Award. Dr. Wu also serves as advisory board member for the FDA Cellular, Tissue, and Gene Therapies Advisory Committee.
Dr. Wu is an elected member of American Society of Clinical Investigators (ASCI), Association of University Cardiologists (AUC), American Institute for Medical and Biological Engineering (AIMBE), American Association of Physicians (AAP), National Academy of Inventors (NAI), and National Academy of Medicine (NAM). https://profiles.stanford.edu/joseph-wu
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1999 - 2004
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1997 - 1999
- Yale School of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 1998 - 2026
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction Start of enrollment: 2022 Mar 22
Roles: Contact, Sponsor-Investigator
Publications & Presentations
PubMed
- 7 citationsElectronic Cigarettes: Where There Is Smoke There Is DiseaseJoseph C. Wu, June-Wha Rhee, Karim Sallam
Journal of the American College of Cardiology. 2019-12-24 - 93 citationsLoss of CDKN2B Promotes p53-Dependent Smooth Muscle Cell Apoptosis and Aneurysm FormationNicholas J. Leeper, Azad Raiesdana, Yoko Kojima, Ramendra K. Kundu, Henry S. Cheng
Arteriosclerosis, Thrombosis, and Vascular Biology. 2013-01-01 - 894 citationsInduced pluripotent stem cell technology: a decade of progressYanhong Shi, Haruhisa Inoue, Joseph C. Wu, Shinya Yamanaka
Nature Reviews. Drug Discovery. 2017-02-01
Journal Articles
- Telomere Shortening Is a Hallmark of Genetic CardiomyopathiesChristine E Seidman, John T Hinson, Gerhard Weber, Euan Ashley, John W Day, Joseph C Wu, Proceedings of the National Academy of Sciences
Authored Content
- Novel PET Tracer Successfully Images Cardiovascular InfectionsJune 2018
- Induced Pluripotent Stem Cells: At the Heart of Cardiovascular Precision MedicineMarch 2016
Press Mentions
- How Space Became a Place for the Study of AgingSeptember 6th, 2024
- Cardiovascular Symposium Will Bring Together Experts from Stanford, ChinaAugust 24th, 2017
- Tumors Caused by Pluripotent Stem Cells Can Be Tackled with Radiation, Say Stanford ResearchersJuly 27th, 2017
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: